Dr.Reddy's Laboratories Ltd (RDY.N)

RDY.N on New York Stock Exchange

21 May 2015
Change (% chg)

$-0.26 (-0.46%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for RDY.N


Dr.Reddy's Laboratories Ltd is an India-based integrated global pharmaceutical company that provides medicines. The Company derives its revenue from the sale of finished dosage forms, active pharmaceutical ingredients and intermediates, development and manufacturing services provided to pharmaceutical and biotechnology... (more)


Beta: 0.80
Market Cap(Mil.): $9,697.47
Shares Outstanding(Mil.): 170.38
Dividend: 0.29
Yield (%): 0.51


  RDY.N Industry Sector
P/E (TTM): 27.80 36.73 38.68
EPS (TTM): 2.04 -- --
ROI: -- 16.14 15.49
ROE: -- 16.91 16.50
Search Stocks

Dr.Reddy's in talks to buy UCB India business for $135 mln - source

MUMBAI, March 10 - Indian drugmaker Dr.Reddy's Laboratories Ltd is in talks to acquire the Indian operations of Belgian pharmaceutical company UCB SA for about $135 million, said a person with direct knowledge of the matter.

10 Mar 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: GlobalData
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks